Showing 1 - 10 of 1,416
this paper is an observation-based analysis conducted by visiting selected paper mills in Finland, the U.S., Germany and … relatively similar firms lends credence to the insights provided by Denrell, Fang and Winter (2003) and Zott (2003), among others … innovative activity in traditional industries such as pulp and paper. -- incremental innovation, ICT investments, modernization …
Persistent link: https://www.econbiz.de/10003850304
In this paper we replicate most of the stylized facts characterizing the decline in business dynamism in the USA highlighted by Akcigit and Ates (2021) and provide an explanation of their emergence by means of a macroeconomic agent-based model populated by two types of firms: innovators who...
Persistent link: https://www.econbiz.de/10014383652
innovation, we characterize such "radical teams" as those formed by eclectic and non-usual collaborators, and those that are …
Persistent link: https://www.econbiz.de/10011451136
Persistent link: https://www.econbiz.de/10010528820
Using Dutch data we empirically investigate how financing and innovation vary across firm characteristics. We find that … when firms face financial constraints, debt financing and innovation choices are not independent of firm characteristics …
Persistent link: https://www.econbiz.de/10010249680
Trade and growth theories predict a mutual causation of innovation and exports. We test empirically whether innovation … exogenous to firms export performance. We find that innovation attributable to this variation leads to an increase of roughly 7 …
Persistent link: https://www.econbiz.de/10011402447
The paper aims at assessing discrete complementarities in innovation policies in the context of the Brazilian industry … in 2003. The paper considers the approach advanced by Mohnen and and Röller [European Economic Review, 2005] that focuses … on supermodularity and submodularity tests for obstacles to innovation (in the present application: lack of finance …
Persistent link: https://www.econbiz.de/10003883864
I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-adjusted mortality rates of residents of Germany, using longitudinal, annual, state-level data during the period 2000-2007. The estimates …-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer …
Persistent link: https://www.econbiz.de/10003977959
Persistent link: https://www.econbiz.de/10003623797
Persistent link: https://www.econbiz.de/10003495613